0000950144-01-507049.txt : 20011008
0000950144-01-507049.hdr.sgml : 20011008
ACCESSION NUMBER: 0000950144-01-507049
CONFORMED SUBMISSION TYPE: SC 13D/A
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20010919
GROUP MEMBERS: NEVON INC
GROUP MEMBERS: NEVON VENTURES LIMITED PARTNER
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVEN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000815838
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 592767632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-40243
FILM NUMBER: 1740449
BUSINESS ADDRESS:
STREET 1: 11960 SW 144TH ST
CITY: MIAMI
STATE: FL
ZIP: 33186
BUSINESS PHONE: 3052535099
MAIL ADDRESS:
STREET 1: 11960 SW 144TH STREET
CITY: MIAMI
STATE: FL
ZIP: 33185
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: SABLOTSKY STEVEN
CENTRAL INDEX KEY: 0001037762
STANDARD INDUSTRIAL CLASSIFICATION: []
FILING VALUES:
FORM TYPE: SC 13D/A
BUSINESS ADDRESS:
STREET 1: 11960 SW 144 ST
CITY: MIAMI
STATE: FL
ZIP: 33186
BUSINESS PHONE: 3052535099
MAIL ADDRESS:
STREET 1: 11960 SW 144 ST
CITY: MIAMI
STATE: FL
ZIP: 33186
SC 13D/A
1
g70699sc13da.txt
NOVEN PHARMACEUTICALS, INC.
1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
NOVEN PHARMACEUTICALS, INC.
---------------------------
(Name of Issuer)
COMMON STOCK, $.0001 PAR VALUE
------------------------------
(Title of Class of Securities)
670009-10-9
-----------
(Cusip Number)
STEVEN SABLOTSKY
3305 WEST SPRING MOUNTAIN ROAD, SUITE 60, LAS VEGAS, NEVADA 89102
-----------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
JULY 10, 2001
-----------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original and five
copies of this schedule, including all exhibits. See ss. 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act.
(Continued on following page(s))
Page 1
2
---------------------------------- ---------------------------
CUSIP NO. 670009-10-9 13D PAGE 2
---------------------------------- ---------------------------
--------- ----------------------------------------------------------------------
1 Names of Reporting Persons
I.R.S. Identification No. of Above Person
STEVEN SABLOTSKY
--------- ----------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [X]
(b) [ ]
--------- ----------------------------------------------------------------------
3 SEC Use Only
--------- ----------------------------------------------------------------------
4 Source of Funds
OO
--------- ----------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) [ ]
--------- ----------------------------------------------------------------------
6 Citizenship or Place of Organization
USA
-------------------------- ------ ----------------------------------------------
NUMBER OF 7 Sole Voting Power
SHARES 1,068,314
BENEFICIALLY ------ -----------------------------------------------
OWNED BY 8 Shared Voting Power
EACH REPORTING 0
PERSON WITH ------ ----------------------------------------------
9 Sole Dispositive Power
1,068,314
------ ----------------------------------------------
10 Shared Dispositive Power
0
--------- ----------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,068,314
--------- ----------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares
[ ]
--------- ----------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
4.8%
--------- ----------------------------------------------------------------------
14 Type of Reporting Person
IN
--------- ----------------------------------------------------------------------
Page 2
3
---------------------------------- ---------------------------
CUSIP NO. 670009-10-9 13D PAGE 3
---------------------------------- ---------------------------
--------- ----------------------------------------------------------------------
1 Names of Reporting Persons
I.R.S. Identification No. of Above Person
NEVON VENTURES LIMITED PARTNERSHIP
--------- ----------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a)[X]
(b)[ ]
--------- ----------------------------------------------------------------------
3 SEC Use Only
--------- ----------------------------------------------------------------------
4 Source of Funds
OO
--------- ----------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) [ ]
--------- ----------------------------------------------------------------------
6 Citizenship or Place of Organization
NEVADA
-------------------------- ------ ----------------------------------------------
NUMBER OF 7 Sole Voting Power
SHARES 0
BENEFICIALLY ------ ----------------------------------------------
OWNED BY 8 Shared Voting Power
EACH REPORTING 694,100
PERSON WITH ------ ----------------------------------------------
9 Sole Dispositive Power
0
------ ----------------------------------------------
10 Shared Dispositive Power
694,100
--------- ----------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
694,100
--------- ----------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares
[ ]
--------- ----------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
3.1%
--------- ----------------------------------------------------------------------
14 Type of Reporting Person
PN
--------- ----------------------------------------------------------------------
Page 3
4
---------------------------------- ---------------------------
CUSIP NO. 670009-10-9 13D PAGE 4
---------------------------------- ---------------------------
--------- ----------------------------------------------------------------------
1 Names of Reporting Persons
I.R.S. Identification No. of Above Person
NEVON, INC.
--------- ----------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a)[X]
(b)[ ]
--------- ----------------------------------------------------------------------
3 SEC Use Only
--------- ----------------------------------------------------------------------
4 Source of Funds
OO
--------- ----------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) [ ]
--------- ----------------------------------------------------------------------
6 Citizenship or Place of Organization
USA
-------------------------- ------ ----------------------------------------------
NUMBER OF 7 Sole Voting Power
SHARES 0
BENEFICIALLY ------ ----------------------------------------------
OWNED BY 8 Shared Voting Power
EACH REPORTING 694,100
PERSON WITH ------ ----------------------------------------------
9 Sole Dispositive Power
0
------ ----------------------------------------------
10 Shared Dispositive Power
694,100
--------- ----------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
694,100
--------- ----------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares
[ ]
--------- ----------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
3.1%
--------- ----------------------------------------------------------------------
14 Type of Reporting Person
CO
--------- ----------------------------------------------------------------------
Page 4
5
AMENDMENT NO. 2 TO SCHEDULE 13D
Item 1. SECURITY AND ISSUER.
This Amendment No. 2 to Schedule 13D is filed jointly by Steven
Sablotsky, Nevon Ventures Limited Partnership (the "Partnership") and Nevon,
Inc. (collectively, the "Reporting Persons") with respect to the Common Stock,
$.0001 par value (the "Common Stock"), of Noven Pharmaceuticals, Inc. (the
"Issuer").
Item 2. IDENTITY AND BANKGROUND
On July 10, 2001, Mr. Sablotsky resigned from the Board of Directors of
the Issuer, and Mr. Sablotsky is no longer a director or an officer of the
Issuer. Mr. Sablotsky's principal business address is 3305 West Spring Mountain
Road, Suite 60, Las Vegas, Nevada 89102.
Item 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5 is amended and restated in its entirety as follows:
As of July 10, 2001, the Reporting Persons beneficially owned the
following Shares:
AMOUNT OF SHARES PERCENTAGE OF
NAME BENEFICIALLY OWNED (D) CLASS (1)
---- ---------------------- ------
Steven Sablotsky(2) 1,068,314 4.8%
Nevon Ventures
Limited Partnership 694,100 3.1%
Nevon, Inc. 694,100 3.1%
--------------------
(1) Based on 22,271,742 shares of Common Stock issued and outstanding as
reported on the Issuer's Form 10-Q for the quarterly period ended March
31, 2001 filed on May 14, 2001 and assumes the exercise of options to
acquire 26,844 Shares exercisable within 60 days of July 10, 2001.
(2) Includes 694,100 Shares held by the Partnership, a limited partnership
of which Mr. Sablotsky is the sole limited partner. The Partnership is
controlled by its sole general partner, Nevon, Inc. Mr. Sablotsky is
the sole shareholder, director and officer of Nevon, Inc. Also includes
347,370 Shares owned directly by Mr. Sablotsky and options to purchase
26,844 Shares owned directly by Mr. Sablotsky and exercisable within 60
days of July 10, 2001.
The Partnership shares the power to vote or dispose of the Shares
beneficially owned by it with Nevon, Inc. and Mr. Sablotsky. Nevon, Inc., in its
capacity as the general partner of the Partnership, has the power to vote or
direct the vote of these Shares or to dispose or direct the disposition of the
Shares for the Partnership. Nevon, Inc. will be deemed the beneficial owner of
the Shares owned by the Partnership by virtue of this relationship to the
Page 5
6
Partnership. Mr. Sablotsky, in his capacity as the sole shareholder, a director
and an officer of Nevon, Inc., the general partner of the Partnership, will be
deemed the beneficial owner of all Shares owned by the Partnership by virtue of
his power to vote or direct the vote of the Shares or to dispose or direct the
disposition of the Shares owned by the Partnership.
None of the Reporting Persons engaged in any transactions in the Common
Stock during the past 60 days.
Item 7. MATERIAL TO BE FILED AS EXHIBITS.
1. Joint Filing Agreement.
Page 6
7
SIGNATURES
After reasonable inquiry and to the best of the undersigned's knowledge
and belief, the undersigned certify that the information set forth in this
Statement is true, complete and correct.
Date: September 19, 2001 /s/ STEVEN SABLOTSKY
---------------------------------------
Steven Sablotsky
NEVON VENTURES LIMITED
PARTNERSHIP, a Nevada limited
partnership
By: NEVON, INC., a Nevada
corporation and its General
Partner
Date: September 19, 2001 By: /s/ STEVEN SABLOTSKY
-----------------------------------
Steven Sablotsky, President
NEVON, INC., a Nevada corporation
Date: September 19, 2001 By: /s/ STEVEN SABLOTSKY
-----------------------------------
Steven Sablotsky, President
Page 7
EX-99.1
3
g70699ex99-1.txt
JOINT FILING AGREEMENT
1
EXHIBIT 1
JOINT FILING AGREEMENT
The undersigned hereby agree that this Amendment No. 2 to the Schedule
13D filed by us with respect to the Common Stock of Noven Pharmaceuticals, Inc.
is filed on behalf of each of us.
Date: September 19, 2001 /s/ STEVEN SABLOTSKY
---------------------------------------
Steven Sablotsky
NEVON VENTURES LIMITED PARTNERSHIP, a
Nevada limited partnership
By: NEVON, INC., a Nevada corporation
and its General Partner
Date: September 19, 2001 By: /s/ STEVEN SABLOTSKY
-----------------------------------
Steven Sablotsky, President
NEVON, INC., a Nevada corporation
Date: September 19, 2001 By: /s/ STEVEN SABLOTSKY
-----------------------------------
Steven Sablotsky, President